Increased percentage of B cells in patients with more advanced hepatocellular carcinoma

Jiunn Chang Lin, Yung Luen Shih, Pei Ju Chien, Chien Liang Liu, Jie Jen Lee, Tsan Pai Liu, Wen Ching Ko, Chwen Ming Shih

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

To compare immunologic phenotypes between (1) hepatocellular carcinoma (HCC) patients and a healthy population and (2) more advanced and early stage HCC patients, we studied 45 HCC patients and 46 healthy controls from January 2006 to January 2008. Using fluorescent activated cell sorter (FACS) analysis, HCC patients were demonstrated to exhibit stronger phagocytosis of granulocytes and monocytes and more peripheral blood mononuclear cells (PBMCs) in the G2/M phase compared with healthy volunteers. By contrast, lower percentages of B and Th lymphocytes were also found in the peripheral blood of HCC patients than in the healthy population. Most importantly, a higher percentage of B cells was found in patients with advanced HCC than in those with early HCC in terms of TNM stage (II and III vs I, p = 0.004), the Japanese Integrated Scoring system (2-3 vs 0-1, p = 0.0235), and tumor numbers (≥2 vs 1, p = 0.005). In conclusion, our findings suggested that HCC patients might exhibit enhanced innate immunity and reduced adaptive immunity compared with healthy volunteers. A higher percentage of B cells was found in patients with more advanced HCC compared with patients with early stage HCC, which might serve as an indicator of the severity of HCC.

Original languageEnglish
Pages (from-to)58-62
Number of pages5
JournalHuman Immunology
Volume71
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Hepatocellular Carcinoma
B-Lymphocytes
Healthy Volunteers
G2 Phase
Adaptive Immunity
Phagocytosis
Granulocytes
Innate Immunity
Cell Division
Population
Monocytes
Blood Cells
Lymphocytes
Phenotype

Keywords

  • B lymphocyte
  • Hepatocellular carcinoma
  • Immunity
  • Lymphocyte subset
  • Phagocytosis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Increased percentage of B cells in patients with more advanced hepatocellular carcinoma. / Lin, Jiunn Chang; Shih, Yung Luen; Chien, Pei Ju; Liu, Chien Liang; Lee, Jie Jen; Liu, Tsan Pai; Ko, Wen Ching; Shih, Chwen Ming.

In: Human Immunology, Vol. 71, No. 1, 01.2010, p. 58-62.

Research output: Contribution to journalArticle

Lin, Jiunn Chang ; Shih, Yung Luen ; Chien, Pei Ju ; Liu, Chien Liang ; Lee, Jie Jen ; Liu, Tsan Pai ; Ko, Wen Ching ; Shih, Chwen Ming. / Increased percentage of B cells in patients with more advanced hepatocellular carcinoma. In: Human Immunology. 2010 ; Vol. 71, No. 1. pp. 58-62.
@article{1d25cda646f34da7aa192e99cd0502a2,
title = "Increased percentage of B cells in patients with more advanced hepatocellular carcinoma",
abstract = "To compare immunologic phenotypes between (1) hepatocellular carcinoma (HCC) patients and a healthy population and (2) more advanced and early stage HCC patients, we studied 45 HCC patients and 46 healthy controls from January 2006 to January 2008. Using fluorescent activated cell sorter (FACS) analysis, HCC patients were demonstrated to exhibit stronger phagocytosis of granulocytes and monocytes and more peripheral blood mononuclear cells (PBMCs) in the G2/M phase compared with healthy volunteers. By contrast, lower percentages of B and Th lymphocytes were also found in the peripheral blood of HCC patients than in the healthy population. Most importantly, a higher percentage of B cells was found in patients with advanced HCC than in those with early HCC in terms of TNM stage (II and III vs I, p = 0.004), the Japanese Integrated Scoring system (2-3 vs 0-1, p = 0.0235), and tumor numbers (≥2 vs 1, p = 0.005). In conclusion, our findings suggested that HCC patients might exhibit enhanced innate immunity and reduced adaptive immunity compared with healthy volunteers. A higher percentage of B cells was found in patients with more advanced HCC compared with patients with early stage HCC, which might serve as an indicator of the severity of HCC.",
keywords = "B lymphocyte, Hepatocellular carcinoma, Immunity, Lymphocyte subset, Phagocytosis",
author = "Lin, {Jiunn Chang} and Shih, {Yung Luen} and Chien, {Pei Ju} and Liu, {Chien Liang} and Lee, {Jie Jen} and Liu, {Tsan Pai} and Ko, {Wen Ching} and Shih, {Chwen Ming}",
year = "2010",
month = "1",
doi = "10.1016/j.humimm.2009.10.003",
language = "English",
volume = "71",
pages = "58--62",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Increased percentage of B cells in patients with more advanced hepatocellular carcinoma

AU - Lin, Jiunn Chang

AU - Shih, Yung Luen

AU - Chien, Pei Ju

AU - Liu, Chien Liang

AU - Lee, Jie Jen

AU - Liu, Tsan Pai

AU - Ko, Wen Ching

AU - Shih, Chwen Ming

PY - 2010/1

Y1 - 2010/1

N2 - To compare immunologic phenotypes between (1) hepatocellular carcinoma (HCC) patients and a healthy population and (2) more advanced and early stage HCC patients, we studied 45 HCC patients and 46 healthy controls from January 2006 to January 2008. Using fluorescent activated cell sorter (FACS) analysis, HCC patients were demonstrated to exhibit stronger phagocytosis of granulocytes and monocytes and more peripheral blood mononuclear cells (PBMCs) in the G2/M phase compared with healthy volunteers. By contrast, lower percentages of B and Th lymphocytes were also found in the peripheral blood of HCC patients than in the healthy population. Most importantly, a higher percentage of B cells was found in patients with advanced HCC than in those with early HCC in terms of TNM stage (II and III vs I, p = 0.004), the Japanese Integrated Scoring system (2-3 vs 0-1, p = 0.0235), and tumor numbers (≥2 vs 1, p = 0.005). In conclusion, our findings suggested that HCC patients might exhibit enhanced innate immunity and reduced adaptive immunity compared with healthy volunteers. A higher percentage of B cells was found in patients with more advanced HCC compared with patients with early stage HCC, which might serve as an indicator of the severity of HCC.

AB - To compare immunologic phenotypes between (1) hepatocellular carcinoma (HCC) patients and a healthy population and (2) more advanced and early stage HCC patients, we studied 45 HCC patients and 46 healthy controls from January 2006 to January 2008. Using fluorescent activated cell sorter (FACS) analysis, HCC patients were demonstrated to exhibit stronger phagocytosis of granulocytes and monocytes and more peripheral blood mononuclear cells (PBMCs) in the G2/M phase compared with healthy volunteers. By contrast, lower percentages of B and Th lymphocytes were also found in the peripheral blood of HCC patients than in the healthy population. Most importantly, a higher percentage of B cells was found in patients with advanced HCC than in those with early HCC in terms of TNM stage (II and III vs I, p = 0.004), the Japanese Integrated Scoring system (2-3 vs 0-1, p = 0.0235), and tumor numbers (≥2 vs 1, p = 0.005). In conclusion, our findings suggested that HCC patients might exhibit enhanced innate immunity and reduced adaptive immunity compared with healthy volunteers. A higher percentage of B cells was found in patients with more advanced HCC compared with patients with early stage HCC, which might serve as an indicator of the severity of HCC.

KW - B lymphocyte

KW - Hepatocellular carcinoma

KW - Immunity

KW - Lymphocyte subset

KW - Phagocytosis

UR - http://www.scopus.com/inward/record.url?scp=71249163387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71249163387&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2009.10.003

DO - 10.1016/j.humimm.2009.10.003

M3 - Article

C2 - 19819282

AN - SCOPUS:71249163387

VL - 71

SP - 58

EP - 62

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 1

ER -